Genxrose-Gold 20 Capsule is a combination pharmaceutical formulation containing Aspirin (75 mg), Rosuvastatin (20 mg), and Clopidogrel (75 mg), designed to provide comprehensive cardiovascular protection. Aspirin, a well-known antiplatelet agent, inhibits cyclooxygenase, thereby reducing thromboxane A2 production and preventing platelet aggregation, which lowers the risk of arterial thrombosis. Rosuvastatin, a potent HMG-CoA reductase inhibitor, effectively reduces low-density lipoprotein cholesterol (LDL-C) levels, contributing to the prevention of atherosclerosis and cardiovascular events. Clopidogrel, another antiplatelet agent, selectively inhibits the ADP receptor on platelet cell membranes, further preventing platelet activation and aggregation. The synergistic action of these three agents makes Genxrose-Gold 20 Capsule particularly useful in the secondary prevention of cardiovascular diseases such as myocardial infarction, ischemic stroke, and peripheral arterial disease. It is indicated for patients at high risk of thrombotic events who require both lipid-lowering therapy and dual antiplatelet therapy. This combination should be used under strict medical supervision due to the increased risk of bleeding associated with dual antiplatelet therapy. Regular monitoring of lipid profiles, liver function, and bleeding parameters is recommended during treatment. Genxrose-Gold 20 Capsule offers an effective, convenient option for comprehensive cardiovascular risk management.